To start, ask about the scope of the product, including what features it has beyond clinical documentation and ask for systemic level evaluation metrics for AI quality, says Suki CEO Punit Soni.

The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing approach.

The bump represents an estimated increase of $750 million in payments when compared to the current fiscal year, CMS says.